rhFL can be cost-effectively and conveniently produced from recombinant E. coli and is capable of delivering cytotoxic drugs into FLT3-expressing primary AML cells and AML cell lines, as we demonstrated in this work. Here, FLT3 is linked to acute myeloid leukemia.